Raghu Chandramohan - Concepedia

Author

Raghu Chandramohan

Memorial Sloan Kettering Cancer Center

Also Known As

Chandramohan R, R Chandramohan, R. Chandramohan, Raghu Chandramohan

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Molecular Oncology (United States)Children's Cancer Center Baylor College of Medicine Texas Children's Hospital

About

Raghu Chandramohan is an author at Memorial Sloan Kettering Cancer Center specializing in cancer research, medicine, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	5.8K
2	Pathology	5	5	3.7K
3	Cell Biology	3	3	2.2K
4	Engineering	2	2	2.2K
5	Health Sciences	1	1	3.4K

Raghu Chandramohan

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Ahmet Zehir, Ryma Benayed, Ronak Shah, Nature Medicine Metastatic CancerOncologySomatic VariantMutational LandscapeTumor Heterogeneity	2017	3.4K
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) Donavan T. Cheng, Talia Mitchell, Ahmet Zehir, Journal of Molecular Diagnostics Tumor BiologyRadiation OncologyOncologyEngineeringSomatic Variant	2015	2.1K
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers Luc G.T. Morris, Raghu Chandramohan, Lyndsay West, JAMA Oncology	2016	224
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway Rajmohan Murali, Raghu Chandramohan, Inga Möller, Oncotarget EngineeringParallel SequencingGeneticsPathologyMyc Amplifications	2015	131
<i>EGFR</i> Kinase Domain Duplication ( <i>EGFR</i> -KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib Jean‐Nicolas Gallant, Jonathan H. Sheehan, Timothy M. Shaver, Cancer Discovery	2015	120
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma Alan L. Ho, Lara Dunn, Eric J. Sherman, Annals of Oncology Surgical OncologyMalignant DiseaseMedicinePathologyPhase Ii Study	2016	115
Frequent <i><scp>IDH2</scp></i><scp>R172</scp> mutations in undifferentiated and poorly‐differentiated sinonasal carcinomas Snjezana Doğan, Deborah J. Chute, Bin Xu, The Journal of Pathology	2017	110
Benchmarking RNA-Seq quantification tools Raghu Chandramohan, Po-Yen Wu, John H. Phan,	2013	47
Somatic genetic alterations in synchronous and metachronous low‐grade serous tumours and high‐grade carcinomas of the adnexa Rajmohan Murali, Pier Selenica, David N. Brown, Histopathology	2018	24
Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma Samara L. Potter, Jacquelyn Reuther, Raghu Chandramohan, Pediatric Blood & Cancer	2020	23

Page 1